drugset / Trial / NCT05645393

Effect of Estradiol Topical Products

NCT05645393

Phase 0 Completed 4 enrolled University of Maryland, Baltimore
Non-randomizedCrossoverOpen-labelBasic science

Summary

The aim of the present study is to determine if two products can deliver bioequivalent amounts of estrogen (estradiol, estriol, and estrone).

Timeline

Start
2024-06-05
Primary completion
2025-03-30
Completion
2025-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Biest Unknown Topical
Comparator Estradiol Other / unclassified 0.06 % Topical
Comparator Estradiol Other / unclassified 1.25 g Topical

Indications

No indication recorded.